FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Hydrocortisone Sodium Succinate Injection
Status: Currently in Shortage
»Date first posted: 03/24/2023
»Therapeutic Categories: Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology

Expand all

Hospira, Inc., a Pfizer Company (Revised 03/28/2024)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Solu-cortef, Injection, 1000 mg/8 mL (NDC 0009-0005-01)	Available
Solu-cortef, Injection, 100 mg/2 mL (NDC 0009-0825-01)	Limited Availability	Limited Supply Available. Next Delivery: March 2024; Estimated Recovery: June 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Delay in shipping of the drug
Solu-cortef, Injection, 100 mg/2 mL (NDC 0009-0011-04)	Available	Dear Healthcare Providers, Customers and Patients Letter
Solu-Cortef, Injection, 100 mg/mL (NDC 0009-0011-03)	Available
Solu-cortef, Injection, 250 mg/2 mL (NDC 0009-0013-06)	Limited Availability	Limited Supply Available. Next Delivery: February 2024; Estimated Recovery: March 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Delay in shipping of the drug
Solu-cortef, Injection, 250 mg/2 mL (NDC 0009-0013-05)	Limited Availability	Limited Supply Available. Next Delivery: February 2024; Estimated Recovery: March 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Delay in shipping of the drug
Solu-cortef, Injection, 500 mg/4 mL (NDC 0009-0016-12)	Limited Availability	Limited Supply Available. Next Delivery and Estimated Recovery: March 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Delay in shipping of the drug